NuMY—A qPCR Assay Simultaneously Targeting Human Autosomal, Y-Chromosomal, and Mitochondrial DNA

The accurate quantification of DNA in forensic samples is of utmost importance. These samples are often present in limited amounts; therefore, it is indicated to use the appropriate analysis route with the optimum DNA amount (when possible). Also, DNA quantification can inform about the degradation...

Full description

Bibliographic Details
Main Authors: Catarina Xavier, Charlotte Sutter, Christina Amory, Harald Niederstätter, Walther Parson
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/14/8/1645
_version_ 1797584643904503808
author Catarina Xavier
Charlotte Sutter
Christina Amory
Harald Niederstätter
Walther Parson
author_facet Catarina Xavier
Charlotte Sutter
Christina Amory
Harald Niederstätter
Walther Parson
author_sort Catarina Xavier
collection DOAJ
description The accurate quantification of DNA in forensic samples is of utmost importance. These samples are often present in limited amounts; therefore, it is indicated to use the appropriate analysis route with the optimum DNA amount (when possible). Also, DNA quantification can inform about the degradation stage and therefore support the decision on which downstream genotyping method to use. Consequently, DNA quantification aids in getting the best possible results from a forensic sample, considering both its DNA quantity and quality limitations. Here, we introduce NuMY, a new quantitative real-time PCR (qPCR) method for the parallel quantification of human nuclear (n) and mitochondrial (mt) DNA, assessing the male portion in mixtures of both sexes and testing for possible PCR inhibition. NuMY is based on previous work and follows the MIQE guidelines whenever applicable. Although quantification of nuclear (n)DNA by simultaneously analyzing autosomal and male-specific targets is available in commercial qPCR kits, tools that include the quantification of mtDNA are sparse. The quantification of mtDNA has proven relevant for samples with low nDNA content when conventional DNA fingerprinting techniques cannot be followed. Furthermore, the development and use of new massively parallel sequencing assays that combine multiple marker types, i.e., autosomal, Y-chromosomal, and mtDNA, can be optimized when precisely knowing the amount of each DNA component present in the input sample. For high-quality DNA extracts, NuMY provided nDNA results comparable to those of another quantification technique and has also proven to be a reliable tool for challenging, forensically relevant samples such as mixtures, inhibited, and naturally degraded samples.
first_indexed 2024-03-10T23:54:36Z
format Article
id doaj.art-ae0e24c9ca0c446c8c9030bb4c33a9a6
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-10T23:54:36Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-ae0e24c9ca0c446c8c9030bb4c33a9a62023-11-19T01:16:26ZengMDPI AGGenes2073-44252023-08-01148164510.3390/genes14081645NuMY—A qPCR Assay Simultaneously Targeting Human Autosomal, Y-Chromosomal, and Mitochondrial DNACatarina Xavier0Charlotte Sutter1Christina Amory2Harald Niederstätter3Walther Parson4Institute of Legal Medicine, Medical University of Innsbruck, 6020 Innsbruck, AustriaInstitute of Legal Medicine, Medical University of Innsbruck, 6020 Innsbruck, AustriaInstitute of Legal Medicine, Medical University of Innsbruck, 6020 Innsbruck, AustriaInstitute of Legal Medicine, Medical University of Innsbruck, 6020 Innsbruck, AustriaInstitute of Legal Medicine, Medical University of Innsbruck, 6020 Innsbruck, AustriaThe accurate quantification of DNA in forensic samples is of utmost importance. These samples are often present in limited amounts; therefore, it is indicated to use the appropriate analysis route with the optimum DNA amount (when possible). Also, DNA quantification can inform about the degradation stage and therefore support the decision on which downstream genotyping method to use. Consequently, DNA quantification aids in getting the best possible results from a forensic sample, considering both its DNA quantity and quality limitations. Here, we introduce NuMY, a new quantitative real-time PCR (qPCR) method for the parallel quantification of human nuclear (n) and mitochondrial (mt) DNA, assessing the male portion in mixtures of both sexes and testing for possible PCR inhibition. NuMY is based on previous work and follows the MIQE guidelines whenever applicable. Although quantification of nuclear (n)DNA by simultaneously analyzing autosomal and male-specific targets is available in commercial qPCR kits, tools that include the quantification of mtDNA are sparse. The quantification of mtDNA has proven relevant for samples with low nDNA content when conventional DNA fingerprinting techniques cannot be followed. Furthermore, the development and use of new massively parallel sequencing assays that combine multiple marker types, i.e., autosomal, Y-chromosomal, and mtDNA, can be optimized when precisely knowing the amount of each DNA component present in the input sample. For high-quality DNA extracts, NuMY provided nDNA results comparable to those of another quantification technique and has also proven to be a reliable tool for challenging, forensically relevant samples such as mixtures, inhibited, and naturally degraded samples.https://www.mdpi.com/2073-4425/14/8/1645DNA quantificationhuman nuclear DNAY chromosomemitochondrial DNA
spellingShingle Catarina Xavier
Charlotte Sutter
Christina Amory
Harald Niederstätter
Walther Parson
NuMY—A qPCR Assay Simultaneously Targeting Human Autosomal, Y-Chromosomal, and Mitochondrial DNA
Genes
DNA quantification
human nuclear DNA
Y chromosome
mitochondrial DNA
title NuMY—A qPCR Assay Simultaneously Targeting Human Autosomal, Y-Chromosomal, and Mitochondrial DNA
title_full NuMY—A qPCR Assay Simultaneously Targeting Human Autosomal, Y-Chromosomal, and Mitochondrial DNA
title_fullStr NuMY—A qPCR Assay Simultaneously Targeting Human Autosomal, Y-Chromosomal, and Mitochondrial DNA
title_full_unstemmed NuMY—A qPCR Assay Simultaneously Targeting Human Autosomal, Y-Chromosomal, and Mitochondrial DNA
title_short NuMY—A qPCR Assay Simultaneously Targeting Human Autosomal, Y-Chromosomal, and Mitochondrial DNA
title_sort numy a qpcr assay simultaneously targeting human autosomal y chromosomal and mitochondrial dna
topic DNA quantification
human nuclear DNA
Y chromosome
mitochondrial DNA
url https://www.mdpi.com/2073-4425/14/8/1645
work_keys_str_mv AT catarinaxavier numyaqpcrassaysimultaneouslytargetinghumanautosomalychromosomalandmitochondrialdna
AT charlottesutter numyaqpcrassaysimultaneouslytargetinghumanautosomalychromosomalandmitochondrialdna
AT christinaamory numyaqpcrassaysimultaneouslytargetinghumanautosomalychromosomalandmitochondrialdna
AT haraldniederstatter numyaqpcrassaysimultaneouslytargetinghumanautosomalychromosomalandmitochondrialdna
AT waltherparson numyaqpcrassaysimultaneouslytargetinghumanautosomalychromosomalandmitochondrialdna